🇺🇸 Mycophenolate mofetil therapy in United States

Mycophenolate mofetil therapy (Mycophenolate mofetil therapy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Mycophenolate mofetil therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Mycophenolate mofetil therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Mycophenolate mofetil therapy in United States?

National Medical Research Center for Children's Health, Russian Federation is the originator. The local marketing authorisation holder may differ — check the official source linked above.